Connect with us

Business

Stock market news live updates: Dow falls, but heads toward best month in more than three decades – Yahoo Canada Shine On

Published

 on


GlobeNewswire

Biological Seed Treatment Market to be worth USD 2,037.5 Million By 2027 | Reports and Data

The rising demand in the agricultural sector for food grains and the scarcity of arable lands are driving the demand for the Biological Seed Treatment market.New York, Nov. 30, 2020 (GLOBE NEWSWIRE) — The Global Biological Seed Treatment Market is forecast to reach USD 2,037.5 million by 2027, according to a new report by Reports and Data. Rising demand in the agriculture sector for food grains and growing R&D to increase crop yield and seed potential is expected to drive the growth of the biological seed treatment market. The growing focus on organic farming in the agricultural sector is most likely to fuel the demand for biological seed treatment over the forecast period. The escalating need to enhance plant nutrients’ availability in the root system is boosting the demand for biological seed treatment solutions. The increasing awareness pertaining to the adverse effects of chemical seed treatment among health-conscious consumers is furthering the utilization of biological seed treatment solutions.The high cost associated with biological seed treatments and the lack of awareness among farmers regarding sustainable agricultural practices is restricting the growth of the biological seed treatment market over the forecast period.  Get FREE Sample Copy with TOC of the Report to understand the structure of the complete report@ https://www.reportsanddata.com/sample-enquiry-form/3696Further key findings from the report suggest * The increasing demand in the agricultural sector for food grains and scarcity of arable lands are driving the growth of the market. The increase in awareness among consumers regarding the environment and health has propelled the market growth. * The government of several countries has restricted the use of chemical pesticides and is encouraging biological seed treatment products. They are taking initiatives for promoting biological seed treatment products and awarding grants for the research and development of seed treatment products. * The Asia Pacific market is expected to grow at a CAGR of 12.4% over the forecast period, making it the fastest-growing region in the biological seed treatment market. There is a significant demand for biological seed treatment in the region for the minimization of the usage of excessive pesticides. * The biological seed treatment market is adopting some wiser strategies in order to say competitive between the growing demand for the products. Prominent brands in the sector have undertaken collaborations to expand their product portfolios and enter new markets. To retain the position of products in the competitive market, companies are adopting effective marketing and branding strategies. * Key participants include BASF SE, Syngenta International AG, Bayer CropScience AG, DuPont, Monsanto Company, Koppert Biological Systems, ADAMA agricultural solutions, Plant Health Care, Incotec, and Verdesian Life Sciences, among others.  BUY NOW (Customized Report Delivered as per Your Specific Requirement)@ https://www.reportsanddata.com/checkout-form/3696For the purpose of this report, Reports and Data has segmented the Global Biological Seed Treatment Market on the basis of product, function, crop type, and region: * Product Outlook (Revenue, USD Million; 2017-2027) * Botanicals & others * Microbials (Fungi, Bacteria) * Function Outlook (Revenue, USD Million; 2017-2027) * Seed Enhancement (Biostimulants, Biofertilizers) * Seed Protection (Biofungicides, Bioinsecticides) * Crop Type Outlook (Revenue, USD Million; 2017-2027) * Wheat * Corn * Sunflower * Cotton * Soybean * Vegetable crops * OthersTo identify the key trends in the industry, click on the link below:   https://www.reportsanddata.com/report-detail/biological-seed-treatment-market * Regional Outlook (Revenue, USD Million; 2017-2027) * North America 1. U.S. 2. Canada * Europe 1. Germany 2. U.K. 3. France 4. BENELUX 5. Rest of Europe * Asia Pacific 1. China 2. Japan 3. South Korea 4. Rest of APAC * MEA 1. Saudi Arabia 2. U.A.E. 3. Rest of MEA * Latin America 1. Brazil 2. Rest of LATAMTake a Look at our Related Reports:Natural Rubber Market Analysis by Product Type (RSS Grade, Latex Concentrate, Solid Block), Distribution Channel (Online, Offline), Application (Automobiles, Gloves, Footwear) and Region – Forecast To 2027Digital Farming Market Size, Share & Analysis, By Component (Hardware, Software, And Others), By Application (Precision Farming, Live Stock Monitoring, Green House Farming, And Others) And By Region – Forecasts To 2027Ornamental Fish Market By Types (Cold-water Fish, Tropical Fish) By Applications (Commercial Application, Residential Application) Forecast 2020 To 2027Fishing Nets and Aquaculture Cages Market By Type (Fishing Nets, Aquaculture Cages) By Application (Individual Application, Commercial Application) Regional Outlook And Forecasts, 2020-2027Dripline Market By Type (PC Dripline, Non-PC Dripline, Others), By Application (Farms, Commercial Greenhouses, Residential Gardeners, Others) And Region- Global Forecasts To 2027About Reports and DataReports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370E-mail: sales@reportsanddata.comLinkdIn | Twitter | BlogsLinkdIn | Twitter | BlogsRead Full Press Release@ https://www.reportsanddata.com/press-release/global-biological-seed-treatment-market CONTACT: Contact Us: John W Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com LinkdIn | Twitter | BlogsLinkdIn | Twitter | Blogs

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Trudeau speaks to Pfizer CEO as delays to vaccine shipments get worse – CP24 Toronto's Breaking News

Published

 on


MIa Rabson, The Canadian Press


Published Thursday, January 21, 2021 4:39PM EST


Last Updated Thursday, January 21, 2021 8:00PM EST

OTTAWA – Prime Minister Justin Trudeau spoke to Pfizer CEO Albert Bourla by phone Thursday, the same day the company informed Canada delays to its shipments of COVID-19 vaccines are going to be even worse than previously thought.

Maj.-Gen. Dany Fortin, the military commander now overseeing the vaccine logistics for the Public Health Agency of Canada, said last week a factory expansion at Pfizer’s Belgium plant was going to slow production, cutting Canada’s deliveries over four weeks in half.

In exchange, Pfizer expects to be able to ship hundreds of millions more doses worldwide over the rest of 2021.

Tuesday, Fortin said Canada would receive 80 per cent of the previously expected doses this week, nothing at all next week, and about half the promised deliveries in the first two weeks of February.

Thursday, he said the doses delivered in the first week of February will only be 79,000, one one-fifth of what was once expected. Fortin doesn’t know yet what will come the week after, but overall, Canada’s doses over three weeks are going to be just one-third of what had been planned.

Trudeau has been under pressure to call Bourla, as the delayed doses force provinces to cancel vaccination appointments and reconsider timing for second doses.

Fortin said some provinces may be hit even harder than others because of limits on the way the Pfizer doses can be split up for shipping. The vaccine is delicate and must be kept ultra frozen until shortly before injecting it. The company packs and ships specialized coolers, with GPS thermal trackers, directly to provincial vaccine sites.

Ontario Premier Doug Ford said earlier this week he doesn’t blame the federal government for the dose delays but wanted Trudeau to do more to push back about it.

“If I was in (Trudeau’s) shoes … I’d be on that phone call every single day. I’d be up that guy’s yin-yang so far with a firecracker he wouldn’t know what hit him,” he said of Pfizer’s executives.

Trudeau informed Ford and other premiers of the call with Bourla during a regular teleconference to discuss the COVID-19 pandemic. Until Thursday, all calls between the federal cabinet and Pfizer had been handled by Procurement Minister Anita Anand.

Ford also spoke to Pfizer Canada CEO Cole Pinnow Wednesday.

Trudeau didn’t suggest the call with Bourla made any difference to the delays, and noted Canada is not the only country affected.

Europe, which on the weekend thought its delayed doses would only be for one week after European Commission President Ursula von der Leyen spoke to Bourla, now seems poised to be affected longer. Italy is so angry it is threatening to sue the U.S.-based drugmaker for the delays.

Mexico said this week it is only getting half its expected shipment this week and nothing at all for the next three weeks. Saudi Arabia and Bahrain also reported delays getting doses. Pfizer Canada spokeswoman Christina Antoniou said more countries were affected but wouldn’t say which ones.

Fortin said Pfizer has promised to deliver four million doses to Canada by the end of March and that is not going to change with the delay. With the current known delivery schedule, the company will have to ship more than 3.1 million doses over 7 1/2 weeks to meet that commitment.

Deliveries from Moderna, the other company that has a COVID-19 vaccine approved for use in Canada, are not affected. Canada has received about 176,000 doses from Moderna to date, with deliveries arriving every three weeks.

Moderna has promised two million doses by the end of March.

Both vaccines require first doses and then boosters several weeks later for full effectiveness. Together Pfizer and Moderna intend to ship 20 million doses to Canada in the spring, and 46 million between July and September. With no other vaccines approved, that means Canada will get enough doses to vaccinate the entire population with two doses by the end of September.

This report by The Canadian Press was first published Jan. 21, 2021.

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Trudeau speaks to Pfizer CEO as delays to vaccine shipments get worse – CP24 Toronto's Breaking News

Published

 on


MIa Rabson, The Canadian Press


Published Thursday, January 21, 2021 4:39PM EST


Last Updated Thursday, January 21, 2021 8:00PM EST

OTTAWA – Prime Minister Justin Trudeau spoke to Pfizer CEO Albert Bourla by phone Thursday, the same day the company informed Canada delays to its shipments of COVID-19 vaccines are going to be even worse than previously thought.

Maj.-Gen. Dany Fortin, the military commander now overseeing the vaccine logistics for the Public Health Agency of Canada, said last week a factory expansion at Pfizer’s Belgium plant was going to slow production, cutting Canada’s deliveries over four weeks in half.

In exchange, Pfizer expects to be able to ship hundreds of millions more doses worldwide over the rest of 2021.

Tuesday, Fortin said Canada would receive 80 per cent of the previously expected doses this week, nothing at all next week, and about half the promised deliveries in the first two weeks of February.

Thursday, he said the doses delivered in the first week of February will only be 79,000, one one-fifth of what was once expected. Fortin doesn’t know yet what will come the week after, but overall, Canada’s doses over three weeks are going to be just one-third of what had been planned.

Trudeau has been under pressure to call Bourla, as the delayed doses force provinces to cancel vaccination appointments and reconsider timing for second doses.

Fortin said some provinces may be hit even harder than others because of limits on the way the Pfizer doses can be split up for shipping. The vaccine is delicate and must be kept ultra frozen until shortly before injecting it. The company packs and ships specialized coolers, with GPS thermal trackers, directly to provincial vaccine sites.

Ontario Premier Doug Ford said earlier this week he doesn’t blame the federal government for the dose delays but wanted Trudeau to do more to push back about it.

“If I was in (Trudeau’s) shoes … I’d be on that phone call every single day. I’d be up that guy’s yin-yang so far with a firecracker he wouldn’t know what hit him,” he said of Pfizer’s executives.

Trudeau informed Ford and other premiers of the call with Bourla during a regular teleconference to discuss the COVID-19 pandemic. Until Thursday, all calls between the federal cabinet and Pfizer had been handled by Procurement Minister Anita Anand.

Ford also spoke to Pfizer Canada CEO Cole Pinnow Wednesday.

Trudeau didn’t suggest the call with Bourla made any difference to the delays, and noted Canada is not the only country affected.

Europe, which on the weekend thought its delayed doses would only be for one week after European Commission President Ursula von der Leyen spoke to Bourla, now seems poised to be affected longer. Italy is so angry it is threatening to sue the U.S.-based drugmaker for the delays.

Mexico said this week it is only getting half its expected shipment this week and nothing at all for the next three weeks. Saudi Arabia and Bahrain also reported delays getting doses. Pfizer Canada spokeswoman Christina Antoniou said more countries were affected but wouldn’t say which ones.

Fortin said Pfizer has promised to deliver four million doses to Canada by the end of March and that is not going to change with the delay. With the current known delivery schedule, the company will have to ship more than 3.1 million doses over 7 1/2 weeks to meet that commitment.

Deliveries from Moderna, the other company that has a COVID-19 vaccine approved for use in Canada, are not affected. Canada has received about 176,000 doses from Moderna to date, with deliveries arriving every three weeks.

Moderna has promised two million doses by the end of March.

Both vaccines require first doses and then boosters several weeks later for full effectiveness. Together Pfizer and Moderna intend to ship 20 million doses to Canada in the spring, and 46 million between July and September. With no other vaccines approved, that means Canada will get enough doses to vaccinate the entire population with two doses by the end of September.

This report by The Canadian Press was first published Jan. 21, 2021.

Let’s block ads! (Why?)



Source link

Continue Reading

Business

New Public Health Order Finalized, Changes Made To Gathering Size – Steinbachonline.com – SteinbachOnline.com

Published

 on


[unable to retrieve full-text content]

  1. New Public Health Order Finalized, Changes Made To Gathering Size – Steinbachonline.com  SteinbachOnline.com
  2. Eased code red restrictions for parts of Manitoba take effect Saturday  CTV News
  3. Manitoba to allow 2 visitors in homes starting Saturday for all but northern region  CBC.ca
  4. Northern Manitoba COVID-19 surge continues, as region reports more than half of province’s 198 new cases  CBC.ca
  5. Northern Manitoba continues to be hit hard by COVID-19; five new deaths in Manitoba  CTV News Winnipeg
  6. View Full coverage on Google News



Source link

Continue Reading

Trending